Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$10.9B
sum of reported positions
Reported positions
86
Changes vs prior quarter
75
18 new · 14 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 115 measured positions in 8 quarters, the typical new or larger position finished +1.6 pts against the S&P 500 and 53% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 3.6M | $1.38B | 12.7% | |
| 3M | $812M | 7.4% | |
| 34.2M | $543M | 5.0% | |
TEVA PHARMACEUTICAL INDS LTD | 15.6M | $528M | 4.8% |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $9.44B | $10.9B |
| Positions | 82 | 86 |
| Biggest line | — | Talen Energy 13% |
| 9.18M | $457M | 4.2% |
| 1.79M | $285M | 2.6% |
| 20.2M | $280M | 2.6% |
| 5.02M | $263M | 2.4% |
| 4M | $256M | 2.3% |
| 23.8M | $254M | 2.3% |
| 2.77M | $239M | 2.2% |
| 4.5M | $232M | 2.1% |
| 8.27M | $217M | 2.0% |
| 900K | $215M | 2.0% |
| 6M | $212M | 1.9% |
| 7M | $183M | 1.7% |
| 4.16M | $180M | 1.7% |
| 1.75M | $178M | 1.6% |
| 10.2M | $176M | 1.6% |
| 7.23M | $175M | 1.6% |
| 1.54M | $164M | 1.5% |
| 1.7M | $148M | 1.4% |
| 7.75M | $139M | 1.3% |
| 2.69M | $137M | 1.3% |
| 11.8M | $134M | 1.2% |
Uniqure N.V. (QURE)
409K shares
Hudson Pacific Properties (HPP)
1.02M shares
Gds Holdings (GDS)
486K shares
Protolabs (PRLB)
486K → 109K shares (−78%)
Omeros (OMER)
657K shares
Eupraxia Pharmaceuticals (EPRX)
691K → 867K shares (+26%)
Edesa Biotech (EDSA)
688K → 670K shares (−3%)
Abeona Therapeutics (ABEO)
609K shares
Carter's, Inc. (CRI)
1.02M → 87K shares (−92%)
Tetra Technologies (TTI)
150K shares
SERVICE PPTYS TR
900K shares
ISHARES TR · PUT
5.15M shares in Q1 2026
PLAYSTUDIOS INC
2.7M shares in Q1 2026
Telephone and Data Systems, Inc. (TDS)
1.85M shares in Q1 2026
CALAVO GROWERS INC
1.42M shares in Q1 2026
Akamai Technologies (AKAM)
1.3M shares in Q1 2026
Embecta (EMBC)
1.04M shares in Q1 2026
Acadia Healthcare (ACHC)
850K shares in Q1 2026
Telesat (TSAT)
844K shares in Q1 2026
Constellation Energy (CEG)
715K shares in Q1 2026
Capri Holdings (CPRI)
675K shares in Q1 2026
Indivior (INDV)
663K shares in Q1 2026
BioMarin Pharmaceutical (BMRN)
441K shares in Q1 2026
Protagonist Therapeutics, Inc. (PTGX)
428K shares in Q1 2026
Helen of Troy (HELE)
366K shares in Q1 2026
